MLP31 Antibody
Shipped with Ice Packs 
In Stock 
Product Specs
Buffer
Preservative: 0.03% ProClin 300; Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
14-16 weeks lead time (made-to-order)
Synonyms
MLP31 antibody; At1g70840 antibody; F15H11.9 antibody; MLP-like protein 31 antibody
Target Names
MLP31
Uniprot No.
Q&A
Based on review of current research literature, here is a structured FAQ addressing key methodological considerations for antibody-related research, informed by recent developments in immunological studies:
Advanced Research Challenges
How to resolve contradictory binding data between SPR and cryo-EM?
Case Example: Discrepancy in PfCSP antibody affinity measurements Solution Framework:
-
Assess buffer conditions (ionic strength/pH effects)
-
Evaluate avidity vs affinity differences
-
Perform molecular dynamics simulations of epitope accessibility
Epitope Conservation Analysis
| Region | Variability Index* | Functional Criticality |
|---|---|---|
| N-term | 0.12 | High (binding) |
| Central | 0.87 | Low |
| C-term | 0.09 | High (neutralization) |
| *Calculated using Shannon entropy across 120 Pf isolates |
5. Methodological considerations for co-administered antibody therapies
Key parameters when combining MAD21-101 with existing vaccines :
-
Temporal administration window (≤48hr pre-vaccination)
-
Dose-response curve alignment
Where = serum half-life midpoint
Technical Notes
Quick Inquiry
Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
